Ventricular Tachycardia, Catecholaminergic Polymorphic, 2 (CPVT2)

Alias:

Catecholaminergic Polymorphic Ventricular Tachycardia 2

Stress-Induced Polymorphic Ventricular Tachycardia

Bidirectional Tachycardia

Vtsip

Cpvt2

Tachycardia, Ventricular, Catecholaminergic Polymorphic, Type 2

Ventricular Tachycardia, Catecholaminergic Polymorphic, 1

Ventricular Tachycardia, Stress-Induced Polymorphic

Malignant Paroxysmal Ventricular Tachycardia

Double Tachycardia Induced by Catecholamines

Paroxysmal Familial Ventricular Fibrillation

Multifocal Ventricular Premature Beats

Multifocal Premature Ventricular Beats

Paroxysmal Ventricular Fibrillation

Syncopal Paroxysmal Tachycardia

Syncopal Tachyarythmia

Multifocal Pvcs

Cvpt2

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Ventricular Tachycardia, Catecholaminergic Polymorphic, 2, also known as catecholaminergic polymorphic ventricular tachycardia 2, is related to ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy and catecholaminergic polymorphic ventricular tachycardia, and has symptoms including seizures and syncope. An important gene associated with Ventricular Tachycardia, Catecholaminergic Polymorphic, 2 is CASQ2 (Calsequestrin 2), and among its related pathways/superpathways are Beta-Adrenergic Signaling and Dopamine-DARPP32 Feedback onto cAMP Pathway. Affiliated tissues include heart and heart-ventricle, and related phenotypes are syncope and polymorphic ventricular tachycardia

Related ID：

MALACARDS：VNT010

OMIM：611938

MESH：D017180